Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

David Becton

Concepts (167)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hemophilia A
2
2009
26
0.580
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2011
1031
0.500
Why?
Leukemia, Myeloid, Acute
4
2010
203
0.390
Why?
Osteosarcoma
2
2016
44
0.330
Why?
von Willebrand Diseases
1
2009
25
0.310
Why?
Hematology
1
2009
28
0.310
Why?
Sclerotherapy
2
2020
46
0.310
Why?
Antineoplastic Agents
5
2016
1222
0.290
Why?
Vascular Malformations
2
2020
103
0.280
Why?
Blood Coagulation Factor Inhibitors
1
2007
3
0.280
Why?
Hemophilia B
1
2007
5
0.270
Why?
Hemostasis, Surgical
1
2007
12
0.270
Why?
Blood Coagulation Factors
1
2007
17
0.270
Why?
Enoxaparin
1
2007
31
0.270
Why?
Blood Loss, Surgical
1
2007
71
0.260
Why?
Child, Preschool
13
2020
4076
0.260
Why?
Venous Thrombosis
1
2007
90
0.250
Why?
Cisplatin
3
2016
285
0.250
Why?
Cyclosporine
1
2005
67
0.240
Why?
Blood Coagulation Disorders
2
2020
40
0.240
Why?
Leukemia
1
2005
67
0.230
Why?
Hemostasis
2
2020
60
0.230
Why?
Cladribine
1
2004
3
0.230
Why?
Bone Regeneration
2
2016
70
0.220
Why?
Histiocytosis, Langerhans-Cell
1
2004
33
0.220
Why?
Retinoblastoma
1
2003
15
0.210
Why?
Retinal Neoplasms
1
2003
13
0.210
Why?
Infant
11
2018
3733
0.210
Why?
Neoplasms
3
2012
1325
0.200
Why?
Neoplasms, Second Primary
1
2003
77
0.200
Why?
Child
14
2020
7248
0.190
Why?
Bone Neoplasms
1
2003
184
0.180
Why?
Thrombelastography
1
2020
26
0.170
Why?
Adolescent
11
2020
6739
0.170
Why?
Bleomycin
1
2018
38
0.140
Why?
Down Syndrome
3
2008
93
0.140
Why?
Antibiotics, Antineoplastic
1
2018
80
0.140
Why?
Osteogenesis, Distraction
2
2016
78
0.130
Why?
Piperazines
2
2016
118
0.130
Why?
Leukemia, Megakaryoblastic, Acute
2
2006
6
0.130
Why?
Leukemia, Myeloid
2
2008
42
0.130
Why?
Humans
21
2020
52483
0.120
Why?
Disease-Free Survival
5
2010
460
0.120
Why?
Imidazoles
1
2016
124
0.120
Why?
Remission Induction
4
2011
218
0.120
Why?
Male
13
2020
26761
0.120
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2009
91
0.120
Why?
Leukocyte Count
2
2005
73
0.110
Why?
Receptors, Tumor Necrosis Factor, Type I
1
2013
39
0.110
Why?
Survival Analysis
4
2010
673
0.100
Why?
Doxorubicin
2
2005
241
0.100
Why?
Cord Blood Stem Cell Transplantation
1
2011
9
0.090
Why?
Sarcoma, Myeloid
1
2011
20
0.090
Why?
Neutropenia
1
2012
115
0.090
Why?
Heart Neoplasms
1
2011
32
0.090
Why?
Treatment Outcome
7
2018
5422
0.090
Why?
Core Binding Factors
1
2010
3
0.080
Why?
Proto-Oncogene Proteins c-kit
1
2010
33
0.080
Why?
Entamoebiasis
1
2009
2
0.080
Why?
Diarrhea, Infantile
1
2009
5
0.080
Why?
Liver Abscess
1
2009
5
0.080
Why?
Listeriosis
1
2009
7
0.080
Why?
Female
10
2020
28171
0.080
Why?
Anemia, Aplastic
1
2009
11
0.080
Why?
Platelet Transfusion
1
2009
33
0.080
Why?
Histocompatibility Testing
1
2008
15
0.080
Why?
Acute Lung Injury
1
2009
28
0.080
Why?
HLA Antigens
1
2008
56
0.070
Why?
Abdominal Pain
1
2009
85
0.070
Why?
Young Adult
5
2020
4329
0.070
Why?
Bone Marrow Transplantation
1
2008
113
0.070
Why?
Hospitals, Pediatric
1
2009
243
0.070
Why?
Retrospective Studies
6
2018
6607
0.070
Why?
Adult
7
2020
14161
0.070
Why?
Infusions, Intravenous
2
2004
220
0.070
Why?
Cardiomyopathies
1
2008
121
0.070
Why?
Mitolactol
1
2005
2
0.060
Why?
GATA1 Transcription Factor
1
2005
7
0.060
Why?
Karyotyping
1
2005
78
0.060
Why?
Gene Expression Regulation, Neoplastic
2
2006
857
0.060
Why?
Tamoxifen
1
2005
60
0.060
Why?
Heart
1
2008
345
0.060
Why?
Receptor Protein-Tyrosine Kinases
1
2004
52
0.060
Why?
Proto-Oncogene Proteins
1
2004
151
0.050
Why?
Immunosuppressive Agents
1
2005
243
0.050
Why?
Humerus
1
2003
16
0.050
Why?
Arkansas
1
2009
2028
0.050
Why?
Tibia
1
2003
113
0.050
Why?
Methotrexate
1
2003
77
0.050
Why?
Mutation
2
2010
1347
0.050
Why?
Survivors
1
2003
120
0.050
Why?
Topotecan
1
2002
17
0.050
Why?
Automation
1
2002
18
0.050
Why?
Tumor Necrosis Factor-alpha
2
2013
399
0.040
Why?
Blood Coagulation Tests
1
2020
20
0.040
Why?
Dose-Response Relationship, Drug
1
2004
1378
0.040
Why?
Blood Flow Velocity
1
2020
95
0.040
Why?
Blood Coagulation
1
2020
64
0.040
Why?
Follow-Up Studies
2
2018
2279
0.040
Why?
Prognosis
3
2012
2099
0.040
Why?
Mice, Inbred C57BL
2
2016
1884
0.040
Why?
Gene Expression Profiling
1
2004
1105
0.040
Why?
Hemorrhage
1
2020
209
0.040
Why?
Daunorubicin
2
2008
13
0.030
Why?
Cytarabine
2
2006
42
0.030
Why?
Mice, Nude
1
2016
265
0.030
Why?
Xenograft Model Antitumor Assays
1
2016
220
0.030
Why?
Random Allocation
1
2016
285
0.030
Why?
Acute Disease
2
2008
373
0.030
Why?
Cluster Analysis
2
2005
233
0.030
Why?
Prospective Studies
2
2012
2481
0.030
Why?
Oligonucleotide Array Sequence Analysis
2
2005
405
0.030
Why?
Interleukin-3
1
2012
12
0.020
Why?
Calcitonin Gene-Related Peptide
1
2012
24
0.020
Why?
Protein Precursors
1
2012
42
0.020
Why?
Calcitonin
1
2012
30
0.020
Why?
Sensitivity and Specificity
2
2006
891
0.020
Why?
Interleukin-8
1
2012
86
0.020
Why?
Interleukin-10
1
2012
84
0.020
Why?
ROC Curve
1
2012
253
0.020
Why?
Fatal Outcome
1
2011
197
0.020
Why?
Mice, Knockout
1
2013
879
0.020
Why?
Interleukin-6
1
2012
278
0.020
Why?
Intensive Care Units
1
2012
243
0.020
Why?
Pilot Projects
1
2012
721
0.020
Why?
Exons
1
2010
102
0.020
Why?
Animals
2
2016
13505
0.020
Why?
Time Factors
2
2008
2968
0.020
Why?
Opportunistic Infections
1
2009
56
0.020
Why?
Echocardiography
1
2011
415
0.020
Why?
Mitoxantrone
1
2008
9
0.020
Why?
Translocation, Genetic
1
2010
265
0.020
Why?
Proportional Hazards Models
1
2008
443
0.020
Why?
Hospitalization
1
2012
736
0.020
Why?
Recurrence
1
2008
672
0.020
Why?
Genetic Predisposition to Disease
1
2010
528
0.020
Why?
Prevalence
1
2010
1006
0.020
Why?
Immunophenotyping
1
2006
117
0.020
Why?
Tomography, X-Ray Computed
1
2011
1165
0.020
Why?
Luciferases
1
2005
48
0.020
Why?
Nucleic Acid Hybridization
1
2005
56
0.020
Why?
Cell Membrane
1
2006
245
0.020
Why?
Diagnosis, Differential
1
2009
1046
0.020
Why?
DNA Primers
1
2005
208
0.020
Why?
Middle Aged
1
2020
13028
0.010
Why?
Transfection
1
2005
357
0.010
Why?
Tumor Cells, Cultured
1
2005
460
0.010
Why?
Core Binding Factor Alpha 3 Subunit
1
2004
1
0.010
Why?
fms-Like Tyrosine Kinase 3
1
2004
20
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
582
0.010
Why?
Magnetic Resonance Imaging
1
2011
1546
0.010
Why?
Benzamides
1
2004
50
0.010
Why?
Risk Assessment
1
2008
1327
0.010
Why?
Risk Factors
1
2012
3889
0.010
Why?
Mice
1
2013
5949
0.010
Why?
Pyrimidines
1
2004
199
0.010
Why?
Nuclear Proteins
1
2004
245
0.010
Why?
DNA Helicases
1
2004
150
0.010
Why?
DNA-Binding Proteins
1
2004
422
0.010
Why?
Predictive Value of Tests
1
2004
944
0.010
Why?
Drug Administration Schedule
1
2002
374
0.010
Why?
Linear Models
1
2002
287
0.010
Why?
Transcription Factors
1
2004
566
0.010
Why?
Neutrophils
1
2002
147
0.010
Why?
Analysis of Variance
1
2002
554
0.010
Why?
Patient Selection
1
2002
259
0.010
Why?
Infant, Newborn
1
2006
2867
0.010
Why?
Becton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description